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Abstract We studied the e¡ect of ageing on the mRNA levels
of mitochondria-encoded polypeptides in human platelets. We
used quantitative real-time reverse transcriptase-polymerase
chain reaction (RT-PCR) to investigate the expression of se-
lected cytochrome c oxidase (COX) genes (subunits I and III)
and Complex I genes (subunits reduced nicotinamide adenine
dinucleotide (NADH) dehydrogenase (ND)1 and ND5) in plate-
lets from young and aged healthy subjects. Northern blot anal-
ysis con¢rmed the PCR results. COX I expression is higher
than that of COX III in both young and aged platelets. A
signi¢cant increase of transcripts for Complex I was found dur-
ing ageing. On the contrary, the mRNA levels of the two COX
subunits did not signi¢cantly vary during ageing.
. 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Ageing is a multifactorial phenomenon involving various
changes at biochemical and morphological levels and is char-
acterized by time-dependent decline in physiological functions.
In particular ageing is associated with energy de¢cit and in-
creased production of reactive oxygen species (ROS). Mito-
chondria are the major source and at the same time are tar-
gets of ROS [1] ; this ‘vicious cycle’ [2] leads to an
accumulation of damages to several molecules including the
mitochondrial DNA (mtDNA) [3]. mtDNA is a circular ge-
nome of 16.5 kb encoding 13 polypeptides involved in oxida-
tive phosphorylation (OXPHOS), two rRNAs (12S and 18S)
and 22 tRNAs and is particularly susceptible to mutations. In
addition, a variety of chronic degenerative diseases that in-
volve brain, heart, muscle, kidney and endocrine glands
have been shown to be connected to some mtDNA mutations
[4,5].
Mitochondrial OXPHOS plays a fundamental role in en-
ergy production; it is located in the inner membrane and
consists of ¢ve major multi-protein complexes. The majority
of the subunits of the complexes are encoded by the nuclear
genome with Complex II entirely encoded by nucleus. Com-
plex I is the largest and the most unexplored one although it
represents the key enzyme of the mitochondrial electron
chain. Furthermore, since seven out of the 13 polypeptides
encoded by mtDNA belong to Complex I (reduced nicotin-
amide adenine dinucleotide (NADH)-coenzyme Q reductase),
it is expected that this enzyme should be mostly a¡ected by
ageing [6]. Progressive age-related OXPHOS impairment has
been described in lymphocytes [7], muscle cells [8] and cardi-
omyocytes [9]. In particular a decrease of the enzymatic ac-
tivity of Complexes I, II and IV in human skeletal muscle and
an altered polypeptide pattern in cytochrome c oxidase (COX)
have been observed [10].
The expression of mitochondrial genes in human cells has
yet to be de¢ned. Most studies on the e¡ect of ageing on the
mitochondrial transcription machinery refer to a non-human
cell model [11^13]. Moreover, in most studies, the analysis
was semiquantitative, such as Northern blotting.
Blood platelets have been recently proposed as biomarkers
of mitochondrial function and ageing-related diseases [14^16]
since they possess mitochondria and may be easily collected
by non-invasive procedures. The rationale to employ platelets
as a biomarker of mitochondrial lesions [17] rests on the as-
sumption that alterations occurring in senescence and age-re-
lated diseases may be present in all cells, and that platelets
may signal generalized bioenergetic de¢ciencies [18]. Platelet
energy production derives mainly from glycolysis [17] and
mitochondria are poorly involved in bioenergetic production.
It is therefore expected that platelets with damaged mitochon-
dria should not be removed by selective pressure, thus allow-
ing their biochemical investigation.
The aim of this study was to quantify the mRNA levels of
mitochondria-encoded polypeptides in human young and aged
platelets. We investigated COX (subunits I and III) and Com-
plex I subunits (NADH dehydrogenase (ND)1 and ND5) ex-
pression in platelets from young and aged subjects, using real-
time reverse transcriptase-polymerase chain reaction (RT-
PCR).
2. Materials and methods
2.1. Healthy subjects
Fourteen young healthy subjects (median age 23 years, range 21^29)
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and nine aged healthy individuals (median age 70 years, range 69^82)
were selected by Operative Unit of Immunohematology and Trans-
fusion, S. Orsola-Malpighi Polyclinic, Bologna Hospital after in-
formed consent.
In another set of experiments, we selected a second group of
healthy subjects (three young, median age 23 years, range 21^29;
¢ve aged, median age 70 years, range 69^82). The RNAs extracted
from the platelets of this group were pooled into two di¡erent samples
(young and aged one). Northern blot analysis and quantitative RT-
PCR have been applied to both pools (young and aged).
2.2. Platelet isolation
Platelets were obtained from 35 ml of whole blood as described by
D’Aurelio et al. [18]. Blood was centrifuged at 150Ug for 15 min. To
avoid leukocyte contamination, only the upper 8/10 of the platelet-
rich plasma (PRP) was collected. PRP was diluted 1:1 with a bu¡er
saline plus 5% sodium citrate and then centrifuged again at 1000Ug
for 10 min. Erythrocyte contamination has been avoided by ammo-
nium sulfate (1%) lysis. Light microscopy examination showed that
the isolated platelets contained no detectable erythrocytes and less
than 0.2% leukocyte contamination.
2.3. RNA extraction
Total RNA was isolated from platelets with Trizol reagent (Gibco
BRL-Life Technologies) according to Chomczynski [19]. DNase treat-
ment was performed to remove any trace of mtDNA (RNeasy Mini
Kit, Qiagen). cDNAs were prepared from 1 Wg RNA template in 50 Wl
reaction mixtures as previously described [20].
2.4. Real-time RT-PCR
The PCR primers and TaqMan probes to amplify and detect ND1,
ND5, COX I and COX III genes were designed using the Primer
Express software version 1.0 (Perkin-Elmer/Applied Biosystems, Fos-
ter City, CA, USA) as shown in Table 1 and were based on GenBank
nucleotide sequences. Quantitative RT-PCR has been performed as
previously described [20]. The probes were purchased labeled with
6-carboxy-£uorescein (FAM) as the reporter dye, and with 6-car-
boxy-tetramethyl-rhodamine (TAMRE) as the quencher of £uores-
cence (Perkin-Elmer/Applied Biosystems). In order to minimize vari-
ability in the results due to di¡erences in the RT e⁄ciency and/or
RNA integrity among the unknown samples, the glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) housekeeping gene was also
tested. The TaqMan-GAPDH control reagents (Perkin-Elmer/Applied
Biosystems) were used to amplify and detect GAPDH. Quantitation
of each of the ¢ve genes was performed using standard curves estab-
lished from plasmids containing their speci¢c sequences. The real-time
PCR was performed on an ABI PRISM 7700 sequence detector, using
the ABI PRISM 7700 sequence detector software 1.6 (Perkin-Elmer/
Applied Biosystems). All the reactions for samples or standard were
run in triplicate. For quanti¢cation, expression of each gene was nor-
malized by comparison with GAPDH expression. Normalized levels
of unknown samples were calculated as the ratios between the inves-
tigated genes (ND1, ND5, COX I, and COX III) and GAPDH.
2.5. Northern blot
5 Wg of RNA from the pools of young and aged individuals were
resuspended in RNA loading bu¡er (50% formamide, 2.2 M formal-
dehyde and 1U electrophoresis bu¡er) and electrophoresed through a
1% agarose gel with 2 mM 4-morpholinepropanesulfonic acid, 0.5
mM sodium acetate and 0.1 mM ethylenediamine tetraacetic acid
(EDTA) as the electrophoresis bu¡er. RNAs were transferred from
the gel onto a nylon membrane and ultraviolet (UV) cross-linked for
1 min. The membrane was prehybridized at 42‡C in prehybridization
mix (50% ultrapure formamide, 1 M NaCl, 1% sodium dodecyl sulfate
(SDS), 10% dextran sulfate and 200 Wg/ml sheared salmon sperm
DNA) for over 4 h.
The cDNA probes used in this study were obtained as follows.
Random primers for cDNAs were prepared from isolated mRNA
by Moloney murine leukemia virus reverse transcriptase (Promega,
Milan, Italy) after PCR ampli¢cation by thermal cycler. An aliquot
of total RNA derived from the same samples of platelets of young
and aged individuals was quanti¢ed spectrophotometrically. Levels of
RNA bound to the Northern blot ¢lter were assessed by gel electro-
phoresis analysis.
3. Results
Using real-time RT-PCR, we quantitated the COX I, COX
III, ND1 and ND5 mRNAs in each sample, using for normal-
ization the housekeeping gene GAPDH. Data are shown in
Fig. 1. A standard curve was then constructed plotting the
cycle threshold (Ct) against the known copy number of each
standard sample. There was a linear decrease of the Ct in
proportion to the log of the starting copy number with a
correlation coe⁄cient ranging from 0.97 to 1.00 in the ¢ve
genes. The signal from each sample was normalized to the
signal obtained from the same RNA non-retro-transcribed
to eliminate any error due to ampli¢cation of RNA templates.
The COX III, ND1 and ND5/GAPDH ratios are quite
Table 1
Primer sequences used for real-time RT-PCR analysis according to the Cambridge sequence
COX I COX III
FW primer 6247-CTG CTA TAG TGG AGG CCG GA-6266 9371-CCA ATG ATG GCG CGA TG-938
RW primer 6319-GGG TGG GAG TAG TTC CCT GC-6300 9438-CTT TTT GGA CAG GTG GTG TGT G-9417
Probe 6268-CAG GAA CAG GTT GAA CAG TCC ACC CTC CC-6296 9389-AAC ACG AGA AAG CAC ATA CCA AGG CCA-9415
ND1 ND5
FW primer 3458-ACG CCA TAA AAC TCT TCA CCA AAG-3481 13278-AGT TAC AAT CGG CAT CAA CCA A-13299
RW primer 3461-TAG TAG AAG AGC GAT GGT GAG AGC TA-3536 13368-CCC GGA GCA CAT AAA TAG TAT GG-13346
Probe 3506-CCA TCA CCC TCT ACA TCA CCG CCC-3529 13311-ATT CCT GCA CAT GTG TAC CCA CGC CTT-13337
Fig. 1. Quantitative RT-PCR TaqMan analysis of mtDNA gene ex-
pression (Complex I: ND1 and ND5 subunits; Complex IV: COX
I and COX III subunits) normalized to GAPDH housekeeping gene
in young and aged individuals. The data are shown as meanT stan-
dard deviation. Relative mRNA levels are the amounts of mRNA
for mitochondrial subunits over mRNA for GAPDH. COX I/COX
III (young) P=0.0001; COX I/COX III (aged) P=0.0065; ND1
(young/aged) P=0.049; ND5 (young/aged) P=0.0049.
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similar in platelets from young individuals (Fig. 1). By con-
trast the COX I/GAPDH ratio was about twice in comparison
with the other genes. The same genes show a di¡erent pattern
of expression in platelets from the aged subjects. COX
I/GAPDH and COX III/GAPDH ratios were signi¢cantly
(P6 0.03) lower than the ratios displayed by ND1 and ND5
genes. In both young and aged groups, the COX I expression
is about twice COX III expression (P6 0.01).
The ND1/GAPDH ratio was signi¢cantly reduced
(P6 0.05) in platelets from young subjects with respect to
platelets from aged ones. A similar pattern was apparent for
the ND5/GAPDH ratio (P6 0.005).
In order to exclude the possibility of artefacts in the PCR
analysis, we have performed a parallel study on two pools
from young and aged individuals (see Section 2) by real-
time PCR and Northern blotting. The results of the real-
time PCR are somewhat di¡erent with respect to the previous
experiment on single individuals shown in Fig. 1 since they
show a low expression level of the COX I and COX III genes
in the pools of the young. Although we cannot compare these
single values with those, statistically signi¢cant, of the pre-
vious set of experiments, it is worth noting that the real-
time PCR data exactly overlap the Northern blot results for
the same pools (Fig. 2).
4. Discussion
In this study we quanti¢ed the mRNA levels of selected
mitochondrial genes in order to verify the e¡ects of ageing
on the mitochondrial transcription process. The interest of
Fig. 2. Comparison of real-time RT-PCR TaqMan analysis and Northern blot analysis of mitochondrial gene expression from two pools of
mtRNA respectively from young and aged individuals. A: Real-time PCR of ND1 and ND5. B: Northern blot of ND1 and ND5. C: Real-
time PCR of COX I and COX III. D: Northern blot of COX I and COX III. Note the low values for COX I and COX III in the young in
this experiment (C). For the Northern blot analysis, total RNA (10 Wg) from each pooled young and aged group was resolved by gel electro-
phoresis in a 1% agarose gel (E) to monitor the amount of RNA in each lane (appreciatively equal amount of 28S and 18S RNA, indicating
equal loading in each lane). For RT-PCR TaqMan data see the legend of Fig. 1.
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this work stems from the use of platelets as pathogenic indi-
cators and markers of ageing and diseases correlated to ageing
[17], since they retain megakaryocyte-derived mRNAs and
protein synthesis activity [21]. The mitochondrial transcript
levels were investigated by real-time RT-PCR TaqMan, due
to the small amounts of RNA that could be recovered from
platelets from a normal blood withdrawal. Nevertheless, two
pooled fractions of platelets from di¡erent individuals showed
overlapping results by the alternative technique of Northern
blotting.
Mitochondrial transcript levels of COX I and COX III sub-
units obtained by real-time RT-PCR analysis and normalized
to GAPDH show that COX I expression is twice that of COX
III in both young and old individuals. This result is surprising
since mitochondrial mRNA transcription is polycistronic and
the holoenzymes analyzed (Complex I and Complex IV) con-
tain equivalent amounts of each subunit. It is therefore likely
that some speci¢c post-transcriptional regulation occurs or a
di¡erent stability of the transcripts leads to this di¡erent
steady-state level. These data are consistent with those pub-
lished by Grossman et al. [22] showing that the expression of
di¡erent COX genes is not regulated by the same set of fac-
tors. By contrast, our results are not consistent with data
obtained from rat tissue. In fact COX I and COX III tran-
script levels have an inhomogeneous pattern in di¡erent rat
tissues although COX I and COX III protein levels do not
appear to be di¡erent [13].
Comparison of the transcript copy number in relation to
ageing shows a signi¢cant increase of transcripts for Complex
I ND5 and ND1 subunits during ageing. On the contrary,
there is no signi¢cant change of transcript copy number for
COX subunits. These results are di¡erent from those found by
other investigators in rat tissues. The RNA species (12S
rRNA and COX I mRNA)/DNA molecule ratio was signi¢-
cantly reduced in senescent brain and heart but was un-
changed in liver [12], whereas in the study of Barazzoni [13]
no signi¢cant changes or low reductions of COX I and COX
III transcripts were found in di¡erent tissues from aged rats.
However, Complex I subunit transcription was not investi-
gated.
Complex I activity in platelets during ageing was studied in
our laboratory: a signi¢cantly di¡erent sensitivity to the spe-
ci¢c inhibitor rotenone was detected as an indicator of altered
energy conservation [15]. In addition we found a bioenergetic
mitochondrial de¢ciency in platelets from aged individuals
using a functional test based on the Pasteur e¡ect [18]. Since
Complex I activity is rate limiting over the whole respiratory
chain [23], it is possible that a higher expression of Complex I
transcripts from platelets of aged individuals could compen-
sate for the Complex I alteration. In general we can postulate
that an upregulation in transcription of mitochondrial genes
seems to compensate the OXPHOS disorders in human plate-
lets during ageing.
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